SYNP-102 – Psilocybin by B.More Inc

Investigational psilocybin proposed for alcohol use disorder in a planned 210-participant Phase 2b study, with funding prioritized. Its relationship to SYNP-101 is unconfirmed. Investigational; not for sale.

Guides about SYNP-102 – Psilocybin

• A California Research Guide to PsilocybinLearn guide
• Reading Oregon’s psilocybin data archiveLearn guide
• Reading a psilocybin research headlineLearn guide
• Psychedelic Education at UC IrvineLearn guide

Related news

• DEA proposes higher 2027 quotas for psilocybin and other psychedelicsNov 10, 2026
• Feds Back Psilocybin and Ibogaine Research Ahead of House HearingNov 14, 2026
• Portland adopts lower enforcement priority for noncommercial psychedelicsNov 10, 2026

Glossary: Psilocybin

More from B.More Inc

• SYNP-101 – Synthetic psilocybinInvestigational
• Uncoded (NYU/NIDA collaborative study) – PsilocybinInvestigational